Should Neoadjuvant Treatment Be Adopted More Widely for Patients With Extremity Soft Tissue Sarcoma in Low-Income Countries?
Main Author: | Ankit Mangla |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society of Clinical Oncology
2023-07-01
|
Series: | JCO Global Oncology |
Online Access: | https://ascopubs.org/doi/10.1200/GO.23.00110 |
Similar Items
-
Extremities Soft Tissue Sarcomas, more Common and as Dangerous as Bone Sarcomas
by: Karen Voltan, et al.
Published: (2020-09-01) -
Neoadjuvant Treatment Options in Soft Tissue Sarcomas
by: Mateusz Jacek Spałek, et al.
Published: (2020-07-01) -
Long-Term Follow-Up of Patients Receiving Neoadjuvant Treatment Modalties for Soft Tissue Sarcomas of the Extremities
by: Miriam Rauch, et al.
Published: (2021-10-01) -
DETECTION OF RECURRENT SOFT TISSUE SARCOMAS OF EXTREMITIES
by: G. V. Zinovyev, et al.
Published: (2017-06-01) -
Local recurrence management of extremity soft tissue sarcoma
by: Bogdan Serban, et al.
Published: (2023-08-01)